Abstract
The PBC is pivotal in generating augmented breathings (sighs), but local endogenous neurotransmitters responsible for control of sigh are not fully understood. Owing to the abundant presence of MORs in the PBC and centrally inhibitory effect of opioids on VT, we hypothesized that endogenous PBC opioids, via action on local MORs, would play an important role in maintaining normal respiration by preventing and/or depressing sighs. In anesthetized and spontaneously breathing rats, we recorded the cardiorespiratory activities before and after microinjection of naloxone methiodide, a MOR antagonist (10 mM, ~15 nl), into the PBC (PBCNLX). PBCNLX triggered sighs or if present, enhanced the frequency of sighs (from 0.7 ± 0.3 to 13.6 ± 1.6 sighs/10 min, P < 0.001). We further defined the effect of intravenous (5 μg/kg) and intracisternal injection of fentanyl (1 μg/kg), a MOR agonist, on the PBCNLX‐induced sighs. The sighs were abolished by intravenous injection of fentanyl and largely suppressed by intracisternal injection. In conclusion, endogenous PBC opioids via action on MORs are essential in maintaining normal respiration by preventing and/or suppressing sighs, consistent with centrally inhibitory effect of exogenous MOR agent on sighs.Grant Funding Source: Supported by HL 107462 and ALA Grant RG‐191095‐N
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.